Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Kentanix Supra International Tbk. (KSIX) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Kentanix Supra International Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Kentanix Supra International Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Kentanix Supra International Tbk. trades at Rp400 (market cap 872.24B, 84.3K 24h volume). The key difference: Kentanix Supra International Tbk. is far larger — about 2.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Kentanix Supra International Tbk. is more actively traded (84.3K versus 7.6K). Which is the better fit depends on your goals.

DGNSKSIX
Market Cap
319B872.24B
Volume
7.6K84.3K
Lot
76843
Turnover
1.74M33.54M
Average Price
229.21397.82
Value
1.74M33.54M
Indicative Equilibrium Price
232412
Indicative Equilibrium Volume
2001

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
KSIX
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Kentanix Supra International Tbk.

PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.

Read more on KSIX